About Aptus Pharmaceuticals
Aptus Pharmaceuticals is a company based in Gaithersburg (United States) founded in 2010. Aptus Pharmaceuticals has raised $6.2 million across 1 funding round from investors including Vital Bio Systems, Emerging Technology Partners and ROMA99. The company has 28 employees as of April 06, 2024. Aptus Pharmaceuticals offers products and services including Pharmaceutical Products and Export Services.
- Headquarter Gaithersburg, United States
- Employees 28 as on 06 Apr, 2024
-
Phone
Locked
-
Website
Locked
- Legal Name Aptus Pharma Ltd.
- Jurisdiction Daskroi, Gujarat, India
-
Annual Revenue
$1.67 M (USD)32.27as on Mar 31, 2023
-
Net Profit
$29.19 K (USD)140.83as on Mar 31, 2023
-
EBITDA
-$723.85 (USD)92.64as on Mar 31, 2023
-
Total Equity Funding
$6.2 M (USD)
in 1 rounds
-
Latest Funding Round
$6.2 M (USD), Series A
May 14, 2011
-
Investors
Vital Bio Systems
& 2 more
-
Employee Count
28
as on Apr 06, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Aptus Pharmaceuticals
Aptus Pharmaceuticals offers a comprehensive portfolio of products and services, including Pharmaceutical Products and Export Services.
Pharmaceutical drugs are manufactured and sold for healthcare purposes, with compliance to international standards being maintained.
International export of pharmaceutical products is handled through a dedicated division, as expansion plans are outlined in the company's profile.
Funding Insights of Aptus Pharmaceuticals
Aptus Pharmaceuticals has successfully raised a total of $6.2M through 1 strategic funding round. The most recent funding activity was a Series A round of $6.2 million completed in May 2011. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Aptus Pharmaceuticals
Aptus Pharmaceuticals has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include Vital Bio Systems, Emerging Technology Partners and ROMA99.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
ROMA99 is recognized as a trusted online gaming platform.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Manufacturing and distributing medical equipment for healthcare specialists in India.
|
Locked | Locked | Locked |
Investor details for Aptus Pharmaceuticals
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Aptus Pharmaceuticals
Investment portfolio details for Aptus Pharmaceuticals
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Aptus Pharmaceuticals
Detailed financials for Aptus Pharmaceuticals
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Aptus Pharmaceuticals Comparisons
Peer comparison for Aptus Pharmaceuticals
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Aptus Pharmaceuticals
Detailed competitors of Aptus Pharmaceuticals
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Aptus Pharmaceuticals
Complete news archive for Aptus Pharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aptus Pharmaceuticals
Aptus Pharmaceuticals was founded in 2010 and raised its 1st funding round 1 year after it was founded.
Aptus Pharmaceuticals is headquartered in Gaithersburg, United States. It is registered at Gaithersburg, Maryland, United States.
Aptus Pharmaceuticals is a funded company, having raised a total of $6.2M across 1 funding round to date.
As of Apr 06, 2024, the latest employee count at Aptus Pharmaceuticals is 28.
Annual revenue of Aptus Pharmaceuticals is $1.67M as on Mar 31, 2023.
Aptus Pharmaceuticals was founded in 2010 and is located in Gaithersburg, United States. Operations are centered in the pharmaceutical sector, where drug discovery and formulation activities are undertaken. Research efforts are directed toward therapeutic solutions, with manufacturing processes handled domestically. The company maintains a presence through its domain aptuspharma.com, serving the healthcare industry in the region.
Aptus Pharmaceuticals offers Pharmaceutical Products and Export Services.
Aptus Pharmaceuticals has 3 investors. Key investors include Vital Bio Systems, Emerging Technology Partners, and ROMA99.